SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew Furst who wrote (184)1/20/1997 9:18:00 AM
From: scaram(o)uche   of 6136
 
I think that Chuck assumes that any hot new drug would be competitive to Viracept rather than potentially complementary, as would be the new Glaxo nucleoside. Hey, Chuck, that's not new news! Sorry, but you're going to have to watch as AGPH continues to climb this week. Those San Diego stocks, ya know.........

The article was actually fairly favorable, and only the terribly naive would bail based on the mistake regarding time to Viracept introduction.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext